Literature DB >> 2502947

Mouse liver phenobarbital-inducible P450 system: purification, characterization, and differential inducibility of four cytochrome P450 isozymes from D2 mouse.

P Honkakoski1, M A Lang.   

Abstract

Three novel cytochrome P450 isozymes were purified from phenobarbital (PB)-treated D2 mouse liver microsomes and compared to the previously characterized coumarin 7-hydroxylase, P450Coh. The molecular masses were 56.5, 55, 51, and 49.5 kDa, and the peaks of the reduced CO complexes were at 450, 447.5, 451.5, and 449 nm for P450PBI, P450PBII, P450PBIII, and P450Coh, respectively. The NH2-terminal sequences suggest that these isozymes belong to the P450 gene subfamilies 2B, 1A, 2C, and 2A, respectively. On the basis of reconstituted activities and microsomal immunoinhibition studies, P450Coh was the sole catalyst of coumarin 7-hydroxylation. P450PBI was the major isozyme catalyzing the high Km 7-pentoxyresorufin O-dealkylation. This reaction was also mediated at a slower rate by the low Km isozyme, P450PBII. P450PBIII contributed significantly to the microsomal O-deethylation of 7-ethoxyresorufin and N-demethylation of benzphetamine. Western blotting and dot immunobinding analyse of microsomes showed that the induction patterns of the isozymes were different. PB and TCPO-BOP induced all isozymes variably: P450PBI (19- and 31-fold), P450PBII (2- and 3-fold), P450PBIII (9- and 4-fold), and P450Coh (about 2-fold). Pyrazole induced only P450Coh, while all other isozymes were decreased by 30 to 60%. The changes in the microsomal amounts of these isozymes correlated generally well with the variation in the immunoinhibitable enzyme activities. On the basis of the structural and catalytic properties, immunochemical characteristics, and induction profiles, all three isozymes were different from each other and from the previously characterized P450Coh. This mouse PB-inducible P450 model may be valuable in further studies on the induction mechanisms of PB and TCPOBOP.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2502947     DOI: 10.1016/0003-9861(89)90160-4

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  10 in total

1.  Increased oxidative DNA damage and hepatocyte overexpression of specific cytochrome P450 isoforms in hepatitis of mice infected with Helicobacter hepaticus.

Authors:  M A Sipowicz; P Chomarat; B A Diwan; M A Anver; Y C Awasthi; J M Ward; J M Rice; K S Kasprzak; C P Wild; L M Anderson
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

2.  Human and mouse liver coumarin 7-hydroxylases do not metabolize warfarin in vitro.

Authors:  P Honkakoski; P Arvela; R Juvonen; M A Lang; M Kairaluoma; O Pelkonen
Journal:  Br J Clin Pharmacol       Date:  1992-03       Impact factor: 4.335

Review 3.  Regulation of cytochrome P450 (CYP) genes by nuclear receptors.

Authors:  P Honkakoski; M Negishi
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

4.  Human placental glutathione S-transferase activity and polycyclic aromatic hydrocarbon DNA adducts as biomarkers for environmental oxidative stress in placentas from pregnant women living in radioactivity- and chemically-polluted regions.

Authors:  Maria Yu Obolenskaya; Nadiya M Teplyuk; Rao L Divi; Miriam C Poirier; Nataliya B Filimonova; Monika Zadrozna; Markku J Pasanen
Journal:  Toxicol Lett       Date:  2010-04-07       Impact factor: 4.372

5.  Response of mouse liver coumarin 7-hydroxylase activity to hepatotoxins: dependence on strain and agent and comparison to other monooxygenases.

Authors:  P Pellinen; F Stenbäck; A Rautio; O Pelkonen; M Lang; M Pasanen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-10       Impact factor: 3.000

6.  Determination of urinary 2-mercaptobenzothiazole (2-MBT), the main metabolite of 2-(thiocyanomethylthio)benzothiazole (TCMTB) in humans and rats.

Authors:  A Manninen; S Auriola; M Vartiainen; J Liesivuori; T Turunen; M Pasanen
Journal:  Arch Toxicol       Date:  1996       Impact factor: 5.153

7.  Tissue and sex-dependent differences in CYP2A activities in hamsters.

Authors:  P Pelkonen; M Lang; M Pasanen
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

8.  Regulation of the mouse liver cytochrome P450 2B subfamily by sex hormones and phenobarbital.

Authors:  P Honkakoski; A Kojo; M A Lang
Journal:  Biochem J       Date:  1992-08-01       Impact factor: 3.857

9.  The inhibition of CYP enzymes in mouse and human liver by pilocarpine.

Authors:  T Kimonen; R O Juvonen; E Alhava; M Pasanen
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

10.  Maternal drug abuse and human term placental xenobiotic and steroid metabolizing enzymes in vitro.

Authors:  P Paakki; H Stockmann; M Kantola; P Wagner; U Lauper; R Huch; E Elovaara; P Kirkinen; M Pasanen
Journal:  Environ Health Perspect       Date:  2000-02       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.